Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Aug 12:15:708510.
doi: 10.3389/fnins.2021.708510. eCollection 2021.

Steroids and Olfactory Training for Postviral Olfactory Dysfunction: A Systematic Review

Affiliations

Steroids and Olfactory Training for Postviral Olfactory Dysfunction: A Systematic Review

Fan Yuan et al. Front Neurosci. .

Abstract

Background: Postviral olfactory dysfunction (PVOD) is a clinical challenge due to limited therapeutic options and poor prognosis. Both steroids and olfactory training have been proved to be effective for olfactory dysfunction with varied etiologies. We sought to perform a systematic review to summarize the evidence of steroids or olfactory training for patients with PVOD. Methods: A systematic literature review using PubMed, Embase, Cochrane Library, and Web of Science was conducted to identify studies assessing olfactory change in patients with PVOD receiving steroid or olfactory training. Results: Of the initial 273 abstracts reviewed, 20 articles with data from 2,415 patients with PVOD were included. Treatments including topical steroids, systemic steroids, classical olfactory training (COT), modified olfactory training (MOT), and olfactory training with steroid were analyzed. Both psychophysical olfactory testing and subjective symptom scores were utilized to assess the olfactory function. The routine use of nasal steroid spray alone during the management of PVOD seems to have no positive effect on olfactory dysfunction. Direct injection of steroid or nasal steroid spray into the olfactory cleft significantly improved the olfactory function in patients with PVOD. Olfactory improvement is greater than that of the natural course of the disease with short-term COT. Patients with PVOD would benefit more from long-term COT (>12 weeks). Treatment duration, various odorants, olfactory training devices, changing the types of odors periodically, different molecular odorants, and different concentrations of odorants tended to increase the efficiency of MOT. Clinically significant improvement after olfactory training was defined as an increase of threshold, discrimination, and identification (TDI) score ≥6. From week 24 to week 36, both COT and MOT groups reached the maximum therapeutic effect regarding the number of participants achieving clinically significant improvement. A combination of local or oral steroids with olfactory training is more efficient than COT only. Conclusion: Olfactory function in patients with PVOD was effectively improved through direct steroid administration in the olfactory cleft, COT, or modification of COT. The addition of topical steroids to COT therapy showed a tendency for greater olfactory improvement in patients with PVOD.

Keywords: olfactory dysfunction; olfactory training; postviral olfactory dysfunction; steroid; systematic review.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
The article selection process for systematic review. URTI, upper respiratory tract infection.
Figure 2
Figure 2
The recovery rate (defined as an increased ≥6 in TDI score) of patients with PVOD who used classical olfactory training with different treatment duration (12, 16, 32, and 56 weeks).
Figure 3
Figure 3
The recovery rate (defined as an increased ≥6 in TDI score) of patients with PVOD who used modified olfactory training with different treatment duration (12, 20, 24, and 36 weeks).

Similar articles

Cited by

References

    1. Abdelalim A. A., Mohamady A. A., Elsayed R. A., Elawady M. A., Ghallab A. F. (2021). Corticosteroid nasal spray for recovery of smell sensation in COVID-19 patients: a randomized controlled trial. Am. J. Otolaryngol. 42:102884. 10.1016/j.amjoto.2020.102884 - DOI - PMC - PubMed
    1. Addison A. B., Wong B., Ahmed T., Macchi A., Konstantinidis I., Huart C., et al. . (2021). Clinical olfactory working group consensus statement on the treatment of post-infectious olfactory dysfunction. J. Allergy Clin. Immunol. 147, 1704–1719. 10.1016/j.jaci.2020.12.641 - DOI - PubMed
    1. Altundag A., Cayonu M., Kayabasoglu G., Salihoglu M., Tekeli H., Saglam O., et al. . (2015). Modified olfactory training in patients with post-infectious olfactory loss. Laryngoscope 125, 1763–1766. 10.1002/lary.25245 - DOI - PubMed
    1. Burns P. B., Rohrich R. J., Chung K. C. (2011). The levels of evidence and their role in evidence-based medicine. Plast. Reconstr. Surg. 128, 305–310. 10.1097/PRS.0b013e318219c171 - DOI - PMC - PubMed
    1. Damm M., Pikart L. K., Reimann H., Burkert S., Göktas Ö., Haxel B., et al. . (2014). Olfactory training is helpful in postinfectious olfactory loss: a randomized, controlled, multicenter study. Laryngoscope 124, 826–831. 10.1002/lary.24340 - DOI - PubMed

Publication types